Indications

• Persistent dyspeptic symptoms with or without ulceration
  
  
• Duodenal and benign gastric ulceration including that associated with NSAID therapy
  
  

Key Benefits

• Cetidine is a histamine H2-receptor antagonist
  
  
• Rapidly inhibits both basal and stimulated gastric secretion of acid; reduces pepsin output